IQGA2_HUMAN - dbPTM
IQGA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID IQGA2_HUMAN
UniProt AC Q13576
Protein Name Ras GTPase-activating-like protein IQGAP2
Gene Name IQGAP2
Organism Homo sapiens (Human).
Sequence Length 1575
Subcellular Localization
Protein Description Binds to activated CDC42 and RAC1 but does not seem to stimulate their GTPase activity. Associates with calmodulin..
Protein Sequence MPHEELPSLQRPRYGSIVDDERLSAEEMDERRRQNIAYEYLCHLEEAKRWMEVCLVEELPPTTELEEGLRNGVYLAKLAKFFAPKMVSEKKIYDVEQTRYKKSGLHFRHTDNTVQWLRAMESIGLPKIFYPETTDVYDRKNIPRMIYCIHALSLYLFKLGIAPQIQDLLGKVDFTEEEISNMRKELEKYGIQMPSFSKIGGILANELSVDEAALHAAVIAINEAVEKGIAEQTVVTLRNPNAVLTLVDDNLAPEYQKELWDAKKKKEENARLKNSCISEEERDAYEELLTQAEIQGNINKVNRQAAVDHINAVIPEGDPENTLLALKKPEAQLPAVYPFAAAMYQNELFNLQKQNTMNYLAHEELLIAVEMLSAVALLNQALESNDLVSVQNQLRSPAIGLNNLDKAYVERYANTLLSVKLEVLSQGQDNLSWNEIQNCIDMVNAQIQEENDRVVAVGYINEAIDEGNPLRTLETLLLPTANISDVDPAHAQHYQDVLYHAKSQKLGDSESVSKVLWLDEIQQAVDDANVDKDRAKQWVTLVVDVNQCLEGKKSSDILSVLKSSTSNANDIIPECADKYYDALVKAKELKSERVSSDGSWLKLNLHKKYDYYYNTDSKESSWVTPESCLYKESWLTGKEIEDIIEEVTVGYIRENIWSASEELLLRFQATSSGPILREEFEARKSFLHEQEENVVKIQAFWKGYKQRKEYMHRRQTFIDNTDSIVKIQSWFRMATARKSYLSRLQYFRDHNNEIVKIQSLLRANKARDDYKTLVGSENPPLTVIRKFVYLLDQSDLDFQEELEVARLREEVVTKIRANQQLEKDLNLMDIKIGLLVKNRITLEDVISHSKKLNKKKGGEMEILNNTDNQGIKSLSKERRKTLETYQQLFYLLQTNPLYLAKLIFQMPQNKSTKFMDTVIFTLYNYASNQREEYLLLKLFKTALEEEIKSKVDQVQDIVTGNPTVIKMVVSFNRGARGQNTLRQLLAPVVKEIIDDKSLIINTNPVEVYKAWVNQLETQTGEASKLPYDVTTEQALTYPEVKNKLEASIENLRRVTDKVLNSIISSLDLLPYGLRYIAKVLKNSIHEKFPDATEDELLKIVGNLLYYRYMNPAIVAPDGFDIIDMTAGGQINSDQRRNLGSVAKVLQHAASNKLFEGENEHLSSMNNYLSETYQEFRKYFKEACNVPEPEEKFNMDKYTDLVTVSKPVIYISIEEIISTHSLLLEHQDAIAPEKNDLLSELLGSLGEVPTVESFLGEGAVDPNDPNKANTLSQLSKTEISLVLTSKYDIEDGEAIDSRSLMIKTKKLIIDVIRNQPGNTLTEILETPATAQQEVDHATDMVSRAMIDSRTPEEMKHSQSMIEDAQLPLEQKKRKIQRNLRTLEQTGHVSSENKYQDILNEIAKDIRNQRIYRKLRKAELAKLQQTLNALNKKAAFYEEQINYYDTYIKTCLDNLKRKNTRRSIKLDGKGEPKGAKRAKPVKYTAAKLHEKGVLLDIDDLQTNQFKNVTFDIIATEDVGIFDVRSKFLGVEMEKVQLNIQDLLQMQYEGVAVMKMFDKVKVNVNLLIYLLNKKFYGK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMPHEELPSLQRPRYG
CCHHHCCCCCCCCCC
50.1626091039
14PhosphorylationPSLQRPRYGSIVDDE
CCCCCCCCCCCCCHH
20.2227696853
16PhosphorylationLQRPRYGSIVDDERL
CCCCCCCCCCCHHHC
15.5419664994
24PhosphorylationIVDDERLSAEEMDER
CCCHHHCCHHHHHHH
39.6020166139
38PhosphorylationRRRQNIAYEYLCHLE
HHHHHHHHHHHHCHH
10.9927642862
62PhosphorylationLVEELPPTTELEEGL
EEEECCCCCCHHHHH
30.8427732954
63PhosphorylationVEELPPTTELEEGLR
EEECCCCCCHHHHHH
44.3327732954
74PhosphorylationEGLRNGVYLAKLAKF
HHHHCCHHHHHHHHH
11.44-
77UbiquitinationRNGVYLAKLAKFFAP
HCCHHHHHHHHHHCC
46.51-
85UbiquitinationLAKFFAPKMVSEKKI
HHHHHCCCCCCCCCE
48.80-
91UbiquitinationPKMVSEKKIYDVEQT
CCCCCCCCEEEHHHH
42.31-
93PhosphorylationMVSEKKIYDVEQTRY
CCCCCCEEEHHHHCC
23.8621253578
102UbiquitinationVEQTRYKKSGLHFRH
HHHHCCCCCCCCCCC
40.60-
103PhosphorylationEQTRYKKSGLHFRHT
HHHCCCCCCCCCCCC
42.3024275569
122PhosphorylationQWLRAMESIGLPKIF
HHHHHHHHHCCCCCC
14.6327251275
137PhosphorylationYPETTDVYDRKNIPR
CCCCCCCCCCCCCCH
16.91-
171UbiquitinationQIQDLLGKVDFTEEE
HHHHHHCCCCCCHHH
38.302190698
171 (in isoform 1)Ubiquitination-38.3021890473
171 (in isoform 2)Ubiquitination-38.3021890473
186 (in isoform 2)Phosphorylation-8.4726699800
186 (in isoform 3)Phosphorylation-8.4726699800
189PhosphorylationMRKELEKYGIQMPSF
HHHHHHHHCCCCCCH
15.3021406692
189 (in isoform 2)Phosphorylation-15.3026699800
189 (in isoform 3)Phosphorylation-15.3026699800
195PhosphorylationKYGIQMPSFSKIGGI
HHCCCCCCHHHCCCH
36.4921406692
197PhosphorylationGIQMPSFSKIGGILA
CCCCCCHHHCCCHHH
27.9221406692
200 (in isoform 2)Phosphorylation-22.3326699800
200 (in isoform 3)Phosphorylation-22.3326699800
208PhosphorylationGILANELSVDEAALH
CHHHCCCCCCHHHHH
22.7324275569
275PhosphorylationENARLKNSCISEEER
HHHHHHHCCCCHHHH
15.9628258704
278PhosphorylationRLKNSCISEEERDAY
HHHHCCCCHHHHHHH
43.1928258704
285PhosphorylationSEEERDAYEELLTQA
CHHHHHHHHHHHHHH
17.7728258704
300UbiquitinationEIQGNINKVNRQAAV
HHHCCHHHHHHHHHH
36.77-
356PhosphorylationFNLQKQNTMNYLAHE
HHHHHCCCHHHHHHH
12.3324275569
373O-linked_GlycosylationLIAVEMLSAVALLNQ
HHHHHHHHHHHHHHH
21.2730379171
396PhosphorylationSVQNQLRSPAIGLNN
HHHHHHCCCCCCCCC
27.5527499020
406UbiquitinationIGLNNLDKAYVERYA
CCCCCCCHHHHHHHH
44.7921890473
406 (in isoform 2)Ubiquitination-44.7921890473
412PhosphorylationDKAYVERYANTLLSV
CHHHHHHHHHHHHHH
7.2421406692
415PhosphorylationYVERYANTLLSVKLE
HHHHHHHHHHHHHHH
22.3921406692
418PhosphorylationRYANTLLSVKLEVLS
HHHHHHHHHHHHHHH
21.9624719451
432PhosphorylationSQGQDNLSWNEIQNC
HCCCCCCCHHHHHHH
33.8224275569
494PhosphorylationDPAHAQHYQDVLYHA
CHHHHHHHHHHHHHH
8.37-
499PhosphorylationQHYQDVLYHAKSQKL
HHHHHHHHHHHCCCC
10.28-
509PhosphorylationKSQKLGDSESVSKVL
HCCCCCCCHHHHHHH
29.9425072903
511PhosphorylationQKLGDSESVSKVLWL
CCCCCCHHHHHHHHH
35.3325072903
513PhosphorylationLGDSESVSKVLWLDE
CCCCHHHHHHHHHHH
26.7330622161
520 (in isoform 2)Ubiquitination-40.29-
562UbiquitinationSDILSVLKSSTSNAN
HHHHHHHHHCCCCCC
39.96-
579PhosphorylationIPECADKYYDALVKA
CHHHHHHHHHHHHHH
13.7121253578
580PhosphorylationPECADKYYDALVKAK
HHHHHHHHHHHHHHH
10.65-
585UbiquitinationKYYDALVKAKELKSE
HHHHHHHHHHHHCCC
55.37-
590UbiquitinationLVKAKELKSERVSSD
HHHHHHHCCCCCCCC
51.90-
591PhosphorylationVKAKELKSERVSSDG
HHHHHHCCCCCCCCC
43.1723401153
595PhosphorylationELKSERVSSDGSWLK
HHCCCCCCCCCCEEE
29.0023917254
596PhosphorylationLKSERVSSDGSWLKL
HCCCCCCCCCCEEEE
43.0423312004
599PhosphorylationERVSSDGSWLKLNLH
CCCCCCCCEEEEEEC
33.9422115753
602UbiquitinationSSDGSWLKLNLHKKY
CCCCCEEEEEECCCC
29.13-
608UbiquitinationLKLNLHKKYDYYYNT
EEEEECCCCCEEECC
32.38-
609PhosphorylationKLNLHKKYDYYYNTD
EEEECCCCCEEECCC
17.6230576142
611PhosphorylationNLHKKYDYYYNTDSK
EECCCCCEEECCCCC
12.5417360941
612PhosphorylationLHKKYDYYYNTDSKE
ECCCCCEEECCCCCC
6.3225159151
613PhosphorylationHKKYDYYYNTDSKES
CCCCCEEECCCCCCC
12.8329978859
615PhosphorylationKYDYYYNTDSKESSW
CCCEEECCCCCCCCC
26.0624719451
617PhosphorylationDYYYNTDSKESSWVT
CEEECCCCCCCCCCC
35.9630576142
624PhosphorylationSKESSWVTPESCLYK
CCCCCCCCCHHHCEE
18.3227251275
630PhosphorylationVTPESCLYKESWLTG
CCCHHHCEECCCCCC
19.6222817900
631UbiquitinationTPESCLYKESWLTGK
CCHHHCEECCCCCCC
32.12-
658PhosphorylationYIRENIWSASEELLL
HHHHHHHHCCHHHHH
20.3725693802
660PhosphorylationRENIWSASEELLLRF
HHHHHHCCHHHHHHH
26.5325693802
671PhosphorylationLLRFQATSSGPILRE
HHHHHHCCCCCCHHH
35.99-
672PhosphorylationLRFQATSSGPILREE
HHHHHCCCCCCHHHH
44.21-
685PhosphorylationEEFEARKSFLHEQEE
HHHHHHHHHHHHHHH
27.7323401153
710PhosphorylationGYKQRKEYMHRRQTF
HHHHHHHHHHHHHHH
10.97-
716PhosphorylationEYMHRRQTFIDNTDS
HHHHHHHHHCCCCHH
22.2728857561
721PhosphorylationRQTFIDNTDSIVKIQ
HHHHCCCCHHHHHHH
27.6325072903
723PhosphorylationTFIDNTDSIVKIQSW
HHCCCCHHHHHHHHH
27.5225072903
735PhosphorylationQSWFRMATARKSYLS
HHHHHHHHHCHHHHH
20.04-
739PhosphorylationRMATARKSYLSRLQY
HHHHHCHHHHHHHHH
26.2524275569
740PhosphorylationMATARKSYLSRLQYF
HHHHCHHHHHHHHHH
16.25-
746PhosphorylationSYLSRLQYFRDHNNE
HHHHHHHHHHHCCCH
12.74-
756UbiquitinationDHNNEIVKIQSLLRA
HCCCHHHHHHHHHHH
40.46-
759PhosphorylationNEIVKIQSLLRANKA
CHHHHHHHHHHHHCC
32.6123401153
770PhosphorylationANKARDDYKTLVGSE
HHCCCCCHHHHCCCC
15.3421552520
771AcetylationNKARDDYKTLVGSEN
HCCCCCHHHHCCCCC
42.2319823609
772PhosphorylationKARDDYKTLVGSENP
CCCCCHHHHCCCCCC
22.05-
782PhosphorylationGSENPPLTVIRKFVY
CCCCCCHHHHHHHHH
21.4724275569
786AcetylationPPLTVIRKFVYLLDQ
CCHHHHHHHHHHHCC
28.2319823617
814UbiquitinationLREEVVTKIRANQQL
HHHHHHHHHHHHHHH
20.70-
823UbiquitinationRANQQLEKDLNLMDI
HHHHHHHHHCCHHHH
75.90-
828SulfoxidationLEKDLNLMDIKIGLL
HHHHCCHHHHHHHHH
4.9421406390
837UbiquitinationIKIGLLVKNRITLED
HHHHHHHCCCCCHHH
40.24-
847PhosphorylationITLEDVISHSKKLNK
CCHHHHHHHHHHHCC
22.8927080861
849PhosphorylationLEDVISHSKKLNKKK
HHHHHHHHHHHCCCC
25.3727080861
856UbiquitinationSKKLNKKKGGEMEIL
HHHHCCCCCCCCEEC
73.99-
860SulfoxidationNKKKGGEMEILNNTD
CCCCCCCCEECCCCC
4.3721406390
866PhosphorylationEMEILNNTDNQGIKS
CCEECCCCCCCHHHH
34.9420068231
872UbiquitinationNTDNQGIKSLSKERR
CCCCCHHHHCCHHHH
52.77-
873PhosphorylationTDNQGIKSLSKERRK
CCCCHHHHCCHHHHH
35.6320068231
875PhosphorylationNQGIKSLSKERRKTL
CCHHHHCCHHHHHHH
39.2920068231
881PhosphorylationLSKERRKTLETYQQL
CCHHHHHHHHHHHHH
28.1927251275
885PhosphorylationRRKTLETYQQLFYLL
HHHHHHHHHHHHHHH
5.72-
890PhosphorylationETYQQLFYLLQTNPL
HHHHHHHHHHHHCHH
18.33-
910UbiquitinationIFQMPQNKSTKFMDT
HHCCCCCCCCCCHHH
55.0121890473
910UbiquitinationIFQMPQNKSTKFMDT
HHCCCCCCCCCCHHH
55.01-
910 (in isoform 1)Ubiquitination-55.0121890473
959PhosphorylationDQVQDIVTGNPTVIK
HHHHHHHCCCCCEEE
31.4129978859
963PhosphorylationDIVTGNPTVIKMVVS
HHHCCCCCEEEEEEE
38.5729978859
970PhosphorylationTVIKMVVSFNRGARG
CEEEEEEECCCCCCC
12.8520873877
1002PhosphorylationDKSLIINTNPVEVYK
CCCEEECCCCHHHHH
30.4124275569
1024UbiquitinationTQTGEASKLPYDVTT
HCCCCCCCCCCCCCH
61.60-
1027PhosphorylationGEASKLPYDVTTEQA
CCCCCCCCCCCHHHC
33.2229396449
1030PhosphorylationSKLPYDVTTEQALTY
CCCCCCCCHHHCCCC
23.0129396449
1031PhosphorylationKLPYDVTTEQALTYP
CCCCCCCHHHCCCCH
26.4229396449
1036PhosphorylationVTTEQALTYPEVKNK
CCHHHCCCCHHHHHH
39.7929396449
1037PhosphorylationTTEQALTYPEVKNKL
CHHHCCCCHHHHHHH
9.7629396449
1083PhosphorylationIAKVLKNSIHEKFPD
HHHHHHHCHHHHCCC
24.6026074081
1106PhosphorylationIVGNLLYYRYMNPAI
HHHHHHHHHCCCCCE
8.6721253578
1172PhosphorylationNNYLSETYQEFRKYF
HHHHHHHHHHHHHHH
11.29-
1178PhosphorylationTYQEFRKYFKEACNV
HHHHHHHHHHHHHCC
18.67-
1249PhosphorylationGSLGEVPTVESFLGE
HHCCCCCCHHHHHCC
41.9224275569
1269PhosphorylationNDPNKANTLSQLSKT
CCCCCCCHHHHHCHH
32.4224275569
1271PhosphorylationPNKANTLSQLSKTEI
CCCCCHHHHHCHHHH
27.3422617229
1276PhosphorylationTLSQLSKTEISLVLT
HHHHHCHHHHEEEEE
34.8620068231
1279PhosphorylationQLSKTEISLVLTSKY
HHCHHHHEEEEEECC
13.2420068231
1283PhosphorylationTEISLVLTSKYDIED
HHHEEEEEECCCCCC
18.7220068231
1284PhosphorylationEISLVLTSKYDIEDG
HHEEEEEECCCCCCC
25.6720068231
1286PhosphorylationSLVLTSKYDIEDGEA
EEEEEECCCCCCCCE
23.1721214269
1296PhosphorylationEDGEAIDSRSLMIKT
CCCCEECCCCEEEEE
20.0421214269
1298PhosphorylationGEAIDSRSLMIKTKK
CCEECCCCEEEEECE
26.6621214269
1349PhosphorylationRAMIDSRTPEEMKHS
HHHHCCCCHHHHHCC
38.7222115753
1356PhosphorylationTPEEMKHSQSMIEDA
CHHHHHCCHHHHHHC
20.5923401153
1358PhosphorylationEEMKHSQSMIEDAQL
HHHHCCHHHHHHCCC
25.4123401153
1380PhosphorylationKIQRNLRTLEQTGHV
HHHHHHHHHHHHCCC
37.5021406692
1384PhosphorylationNLRTLEQTGHVSSEN
HHHHHHHHCCCCCCH
21.6321406692
1388PhosphorylationLEQTGHVSSENKYQD
HHHHCCCCCCHHHHH
26.6821406692
1389PhosphorylationEQTGHVSSENKYQDI
HHHCCCCCCHHHHHH
44.0621406692
1392UbiquitinationGHVSSENKYQDILNE
CCCCCCHHHHHHHHH
39.99-
1393PhosphorylationHVSSENKYQDILNEI
CCCCCHHHHHHHHHH
24.0121406692
1430UbiquitinationQTLNALNKKAAFYEE
HHHHHHHHHHHHHHH
44.64-
1454AcetylationKTCLDNLKRKNTRRS
HHHHHHHHHCCCCCC
68.5325953088
1461PhosphorylationKRKNTRRSIKLDGKG
HHCCCCCCEECCCCC
22.3023401153
1467AcetylationRSIKLDGKGEPKGAK
CCEECCCCCCCCCCC
60.8220167786
1471AcetylationLDGKGEPKGAKRAKP
CCCCCCCCCCCCCCC
68.1720167786
1474AcetylationKGEPKGAKRAKPVKY
CCCCCCCCCCCCCCE
62.6519608861
1489UbiquitinationTAAKLHEKGVLLDID
EHHHHHHCCEEEEHH
43.50-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
716TPhosphorylationKinasePRKACAP17612
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of IQGA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
14Phosphorylation8 (6)VArs7722711
  • Mean platelet volume
27863252
16Phosphorylation8 (8)VArs7722711
  • Mean platelet volume
27863252
875Phosphorylation883 (8)EQrs34968964
  • Mean platelet volume
27863252
881Phosphorylation883 (2)EQrs34968964
  • Mean platelet volume
27863252
885Phosphorylation883;894 (2;9)E;TQ;Irs34968964;rs34950321
  • Mean platelet volume
  • Reticulocyte count
27863252
890Phosphorylation883;894 (7;4)E;TQ;Irs34968964;rs34950321
  • Mean platelet volume
  • Reticulocyte count
27863252

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RAC1_HUMANRAC1physical
8756646
CDC42_HUMANCDC42physical
8756646
TERA_HUMANVCPphysical
28970065

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of IQGA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1471 AND LYS-1474, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.

TOP